April 25th 2024
Despite the disproportionate effects of SARS-CoV-2 infection and severe outcomes on nursing home residents, less than 50% have received the updated 2023/2024 vaccine.
What Do Stakeholders Think About the GAP for Influenza Vaccines' First 10 Years?
December 5th 2016Ten years ago in Geneva, the World Health Organization (WHO) unveiled what is now called the Global Action Plan for Influenza Vaccines (GAP), a comprehensive approach to meeting the demand for vaccines should there be a pandemic anywhere in the world. How is it doing?
Read More
NIH Launches First New HIV Vaccine Efficacy Study in 7 Years in South Africa
November 29th 2016The first HIV vaccine efficacy study in seven years is currently being conducted in South Africa, with researchers testing if a new vaccine regimen called HVTN 702 can provide adequate protection against HIV.
Read More
Measles Control & Eradication Efforts Fall Short of 2015 WHA Goals
November 15th 2016A recent analysis by the Centers for Disease Control and Prevention found that strides have been made in the fight against measles; however, the work still falls short of goals set by the World Health Assembly (WHA).
Read More
A Preponderance of Missed Opportunities to Administer the Human Papillomavirus Vaccine
November 10th 2016Despite the Centers for Disease Control and Prevention's recommendation that the human papillomavirus (HPV) vaccine be routinely given to adolescents and young adults, administration rates for the vaccine are still low.
Read More
Populations at Risk for Flu-associated Complications and Recommended Treatments
October 29th 2016Rebekah Stewart Schicker, MSN, MPH, APRN, Epidemic Intelligence Service (EIS) Officer at the Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases, Influenza Division, discusses which outpatient populations are at highest risk of influenza-associated complications and the recommended treatments for these individuals.
Watch
UNICEF Announces New Deal for Low-cost Five-in-one Vaccine for Children
October 25th 2016The United Nations Children’s Fund (UNICEF) has partnered with six vaccine makers and the Global Alliance for Vaccines and Immunization (GAVI) to offer 450 million doses of an inexpensive pentavalent vaccine for children.
Read More
HPV Vaccine May Need a Redesign Due to Changes in Circulating Strains
October 22nd 2016Changes in strain prevalence indicate that the existing 9-valent HPV vaccines may offer some protection against an additional high-risk strain that is not included in the vaccine (strain 31), potentially due to antigenic similarities with other strains.
Read More
Researchers Discover Effective Vaccine Program for Dengue-Affected Countries
October 20th 2016Researchers at Sanofi Pasteur, have developed a “transmission model” for Dengue and assessed the population impact of vaccination in the 10 countries participating in the Phase III efficacy studies for CYD-TDV/Dengvaxia.
Read More